{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-22-025598","form_type":"8-K","ticker":"NUS","cik":"0001021561","company_name":"NU SKIN ENTERPRISES, INC.","filed_at":"2022-07-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:54.617164+00:00","generated_at":"2026-06-24T17:58:34.010734+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Nu Skin prelim Q2 revenue $557-562M, soft due to China COVID, EMEA conflict","bullets":["Estimated Q2 2022 revenue between $557 and $562 million, softer than expected.","COVID-related extended lockdowns in Mainland China and Russia-Ukraine conflict weighed on results.","Growth in Southeast Asia and ongoing U.S. momentum partially offset headwinds.","Company launches ageLOC LumiSpa iO connected beauty device, expects sequential H2 improvements.","Full Q2 results and revised guidance to be released on Aug. 4, 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-22-025598","json":"https://secwatch.observer/filing/0001140361-22-025598.json","markdown":"https://secwatch.observer/filing/0001140361-22-025598.md","text":"https://secwatch.observer/filing/0001140361-22-025598.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1021561/000114036122025598/0001140361-22-025598-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1021561/000114036122025598/brhc10039530_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T17:58:34.010734+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}